A new FDA application for relacorilant shows promising survival benefits in treating platinum-resistant ovarian cancer, ...

Ayal Aizer, MD, MHS, discusses the findings of a phase 3 study investigating the use of stereotactic radiation vs whole-brain radiation in patients with 5 to 20 brain metastases.